JESSICA FRANCIS: Open Payments
NPI 1124042569 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 48 payments from 19 companies in 2025. Trend: 2023 $611 · 2024 $603 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $179 |
| Novo Nordisk Inc | 10 | $155 |
| PFIZER INC. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Mannkind Corporation | 1 | $23 |
Products named: VRAYLAR, Ozempic, REXULTI, JARDIANCE, QULIPTA, Wegovy, EVENITY, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
